X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (492) 492
Publication (110) 110
Book Chapter (6) 6
Conference Proceeding (4) 4
Patent (3) 3
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (217) 217
humans (214) 214
male (129) 129
female (124) 124
middle aged (105) 105
aged (102) 102
pathology (92) 92
article (87) 87
adult (76) 76
cancer (72) 72
oncology (71) 71
tumors (71) 71
surgery (67) 67
aged, 80 and over (63) 63
gastroenterology and hepatology (59) 59
diagnosis (58) 58
animals (52) 52
gastroenterology & hepatology (52) 52
mutation (52) 52
immunohistochemistry (51) 51
abridged index medicus (48) 48
adenocarcinoma (45) 45
pancreatic neoplasms - pathology (44) 44
pancreas (43) 43
prognosis (38) 38
carcinoma (37) 37
lung cancer (37) 37
lung neoplasms - genetics (36) 36
medicine, research & experimental (36) 36
adenocarcinoma - pathology (35) 35
management (35) 35
biopsy (34) 34
respiratory system (34) 34
lung neoplasms - pathology (33) 33
carcinoma, pancreatic ductal - pathology (31) 31
mice (31) 31
research (29) 29
pancreatic cancer (28) 28
retrospective studies (28) 28
care and treatment (27) 27
diagnosis, differential (27) 27
survival (26) 26
classification (25) 25
expression (25) 25
adenocarcinoma, mucinous - pathology (24) 24
medical laboratory technology (23) 23
dysplasia (22) 22
lung neoplasms - drug therapy (21) 21
neoplasm staging (21) 21
cell biology (20) 20
cell line, tumor (20) 20
neoplasms (20) 20
resection (20) 20
carcinoma, non-small-cell lung - genetics (19) 19
chemotherapy (19) 19
mutations (19) 19
young adult (19) 19
adenocarcinoma - genetics (18) 18
pancreas - pathology (18) 18
risk factors (18) 18
sensitivity and specificity (18) 18
swine (18) 18
treatment outcome (18) 18
metastasis (17) 17
pancreatic neoplasms - surgery (17) 17
adolescent (16) 16
features (16) 16
follow-up studies (16) 16
health aspects (16) 16
intraductal papillary mucinous neoplasm (16) 16
carcinoma, pancreatic ductal - surgery (15) 15
crizotinib (15) 15
cytology (15) 15
disease models, animal (15) 15
international consensus guidelines (15) 15
ipmn (15) 15
lung neoplasms - metabolism (15) 15
medical colleges (15) 15
tomography, x-ray computed (15) 15
carcinoma, non-small-cell lung - drug therapy (14) 14
carcinoma, papillary - pathology (14) 14
cells (14) 14
egfr (14) 14
gefitinib (14) 14
gene (14) 14
in situ hybridization, fluorescence (14) 14
lung neoplasms - diagnosis (14) 14
methods (14) 14
patients (14) 14
reproducibility of results (14) 14
usage (14) 14
analysis (13) 13
biomarkers (13) 13
biomarkers, tumor - genetics (13) 13
cysts (13) 13
lung - pathology (13) 13
malignancy (13) 13
multidisciplinary sciences (13) 13
pancreatic neoplasms - diagnosis (13) 13
protein kinase inhibitors - pharmacology (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


TRANSLATIONAL LUNG CANCER RESEARCH, ISSN 2218-6751, 12/2017, Volume 6, Issue Suppl 1, pp. S97 - S98
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 07/2018, Volume 142, Issue 7, pp. 792 - 793
Journal Article
Cancer Biology and Medicine, ISSN 2095-3941, 06/2016, Volume 13, Issue 2, pp. 157 - 170
Blockade of immune checkpoints has recently emerged as a novel therapeutic strategy in various tumors. In particular, monoclonal antibodies targeting... 
Immunohistochemistry | PD-L1 | Biomarker | PD-1 | Predictive | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | ONCOLOGY | B7-H1 EXPRESSION | POOR-PROGNOSIS | IMMUNE ESCAPE | ANTIBODY | PULMONARY ADENOCARCINOMA | BLOCKADE | CLINICOPATHOLOGICAL ANALYSIS | UP-REGULATION | ASSOCIATION | predictive | Review | immunohistochemistry | biomarker
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 07/2017, Volume 125, Issue 7, pp. 521 - 528
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 03/2017, Volume 125, Issue 3, pp. 155 - 160
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 07/2017, Volume 125, Issue 7, pp. 521 - 528
Given the recent approval by the US Food and Drug Administration of an anti‐programmed cell death protein 1 agent as a first‐line therapy for patients with... 
SQUAMOUS-CELL | PEMBROLIZUMAB | NSCLC | ONCOLOGY | PD-L1 EXPRESSION | ADENOCARCINOMAS | ASSAYS | PATHOLOGY | NIVOLUMAB | DOCETAXEL | ASSOCIATION | DIAGNOSTIC IMMUNOHISTOCHEMISTRY
Journal Article
Immunity, ISSN 1074-7613, 02/2016, Volume 44, Issue 2, pp. 343 - 354
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 11/2012, Volume 17, Issue 11, pp. 1351 - 1375
Crizotinib, an ALK/MET/ROS1 inhibitor, was approved by the U.S. Food and Drug Administration for the treatment of anaplastic lymphoma kinase ( ALK )‐rearranged... 
Crizotinib | ROS1 inhibitor | Chromosomal rearrangements | ALK inhibitor | Receptor tyrosine kinase fusion positive malignancies | Non‐small cell lung cancer (NSCLC) | MET inhibitor | Non-small cell lung cancer (NSCLC) | EML4-ALK FUSION GENE | C-MET RECEPTOR | IN-SITU-HYBRIDIZATION | EGFR MUTATION | OPEN-LABEL | ANAPLASTIC LYMPHOMA KINASE | ONCOLOGY | NEVER-SMOKERS | GROWTH-FACTOR | RECEPTOR TYROSINE KINASE | ACTIVATING MUTATIONS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Molecular Targeted Therapy | Genetic Variation | Young Adult | Pyridines - adverse effects | Drug Interactions | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Lung Neoplasms - genetics | Proto-Oncogene Proteins - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | In Situ Hybridization, Fluorescence | Signal Transduction - genetics | Pyrazoles - metabolism | Pyridines - metabolism | Receptor Protein-Tyrosine Kinases - genetics | Gene Rearrangement | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Protein-Tyrosine Kinases - antagonists & inhibitors | Academia-Pharma Intersect
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 8, pp. 863 - 870
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4247 - 4253
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 03/2017, Volume 125, Issue 3, pp. 155 - 160
Because of the advancement of personalized medicine in lung cancer, the subtyping of non–small cell lung cancer and predictive biomarker testing with... 
CANCER PATIENTS | ONCOLOGY | ADENOCARCINOMA | GUIDELINES | CLASSIFICATION | DIFFERENTIATION | PATHOLOGY | DOCETAXEL | EXPRESSION | CELL CARCINOMA | EGFR | IMMUNOHISTOCHEMISTRY
Journal Article
Cancer biology & medicine, ISSN 2095-3941, 06/2016, Volume 13, Issue 2, p. 157
Blockade of immune checkpoints has recently emerged as a novel therapeutic strategy in various tumors. In particular, monoclonal antibodies targeting... 
Journal Article
Diagnostic Cytopathology, ISSN 8755-1039, 04/2014, Volume 42, Issue 4, pp. 338 - 350
The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound... 
PSC | nomenclature | guidelines | terminology | pancreas | DIFFERENTIAL-DIAGNOSIS | ACINAR-CELL CARCINOMA | NEUROENDOCRINE TUMORS | CYST FLUID ANALYSIS | PATHOLOGY |